New Study Evaluates Virtual Reality to Reduce Scanxiety in Brain Tumor Patients

New Study Evaluates Virtual Reality to Reduce Scanxiety in Brain Tumor Patients

A novel VR therapy for psychological symptoms in patients with PBT (primary brain tumors) was analyzed in the interim analysis of a research published in the Journal for Neuro-Oncology. The researchers proposed the possibility and patient acceptance of a VR intervention. Twenty individuals finished the study and received VR headsets with different scenarios preinstalled. Nearly all participants reported frequent usage and great pleasure after experiencing VR for a month. The National Cancer Institute (NCI), a division of the National Institutes of Health (NIH), and AppliedVR collaborated on a phase 2 clinical trial investigation that was conducted today. AppliedVR is an innovator in immersive therapeutics (ITx), pushing a revolutionary approach to medicine. In the phase 2 clinical trial, it was investigated whether VR might be used as a primary brain intervention.




Next Article

Did you find this useful?

Medigy Innovation Network

Connecting innovation decision makers to authoritative information, institutions, people and insights.

Medigy Logo

The latest News, Insights & Events

Medigy accurately delivers healthcare and technology information, news and insight from around the world.

The best products, services & solutions

Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.


© 2024 Netspective Media LLC. All Rights Reserved.

Built on May 23, 2024 at 3:57am